Neil K. Warma was appointed president and chief executive officer of Opexa Therapeutics, Inc., in June 2008. He has more than 19 years of executive-level experience in the life sciences industry in the United States, Europe, and Canada. Prior to joining Opexa, Mr. Warma served as president and CEO and a member of the board of directors of Viron Therapeutics Inc., a privately held clinical stage biopharmaceutical company developing a novel class of protein therapeutics. While at Viron, Mr. Warma positioned the company as a leader in the treatment of serious inflammatory disorders.
Prior to joining Viron, Mr. Warma was co-founder and president of MedExact USA, Inc., an internet company providing clinical information and services to physicians and pharmaceutical companies, which was ultimately sold to a large public European firm. Prior to MedExact, Mr. Warma held several senior management positions at Novartis Pharmaceuticals at its corporate headquarters in Basel, Switzerland, in international policy and advocacy and in global marketing.
Mr. Warma obtained an honors degree specializing in neuroscience from the University of Toronto and an International M.B.A. degree from the Schulich School of Business at York University in Toronto. He currently serves on the board of directors of BioHouston, Inc.